Page last updated: 2024-10-22

acetaminophen and Bone Loss, Perimenopausal

acetaminophen has been researched along with Bone Loss, Perimenopausal in 2 studies

Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Silverman, SL1
Kriegman, A1
Goncalves, J1
Kianifard, F1
Carlson, T1
Leary, E1
Wark, JD1
Bensen, W1
Recknor, C1
Ryabitseva, O1
Chiodo, J1
Mesenbrink, P1
de Villiers, TJ1

Trials

2 trials available for acetaminophen and Bone Loss, Perimenopausal

ArticleYear
Effect of acetaminophen and fluvastatin on post-dose symptoms following infusion of zoledronic acid.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2011, Volume: 22, Issue:8

    Topics: Acetaminophen; Acute-Phase Reaction; Aged; Antipyretics; Bone Density Conservation Agents; Diphospho

2011
Treatment with acetaminophen/paracetamol or ibuprofen alleviates post-dose symptoms related to intravenous infusion with zoledronic acid 5 mg.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2012, Volume: 23, Issue:2

    Topics: Acetaminophen; Aged; Arthralgia; Body Temperature; Bone Density Conservation Agents; Diphosphonates;

2012